Aura Biosciences (AURA) Total Liabilities (2020 - 2026)

Aura Biosciences (AURA) has 7 years of Total Liabilities data on file, last reported at $30.4 million in Q1 2026.

• Quarterly Total Liabilities rose 10.92% year-over-year to $30.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $30.4 million (up 10.92% YoY) and the FY2025 annual result came in at $32.5 million, up 6.5% from the prior year.
• Total Liabilities fell to $30.4 million in Q1 2026, from $32.5 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $33.4 million in Q3 2025 to a low of $5.3 million in Q1 2022.
• A 5-year average of $26.2 million and a median of $28.1 million in 2022 frame the typical range for Total Liabilities.
• The widest YoY moves for Total Liabilities: up 382.78% in 2023, down 0.16% in 2023.
• Tracing AURA's Total Liabilities over 5 years: stood at $28.4 million in 2022, then climbed by 3.09% to $29.2 million in 2023, then advanced by 4.47% to $30.5 million in 2024, then climbed by 6.5% to $32.5 million in 2025, then dropped by 6.42% to $30.4 million in 2026.
• The last three Total Liabilities figures came in at $30.4 million (Q1 2026), $32.5 million (Q4 2025), and $33.4 million (Q3 2025), per Business Quant data.